VASOPRESSIN
| Brand name | VASOSTRICT |
|---|---|
| Active ingredient | VASOPRESSIN |
| Strength | 20UNITS/ML (20UNITS/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | April 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9744209 | January 2035 | use U-1857 |
| 9375478 | January 2035 | use U-1857 |
| 9744239 | January 2035 | use U-1857 |
| 9687526 | January 2035 | use U-1857 |
| 9750785 | January 2035 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.